PLRZ (PLRZ): Company Profile | I3investor
Polyrizon Ltd.

NASDAQ (USD): Polyrizon Ltd. (PLRZ)

Last Price

1.57

Today's Change

-0.76 (32.61%)

Day's Change

1.26 - 2.19

Trading Volume

1,354,158

Profile
PLRZ

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Tomer Izraeli Mr. Tomer Izraeli

Full Time Employees:  1 1

IPO Date:  2024-10-29 2024-10-29

CIK: 

ISIN:  IL0011814113 IL0011814113

CUSIP: 

Beta:  0.00 0.00

Last Dividend:  0.00 0.00

Dcf Diff:  0.00 0.00

Dcf:  0.00 0.00

Description

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

Address

5 Ha-Tidhar Street,
Ra'anana, 4366507, IL

972 9 374 0120

http://www.polyrizon-biotech.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment